Harry L. Leider Gelesis Holdings, Inc. (GLS) insider trading activity

GLS Quotes by TradingView

Harry L. Leider is Chief Medical Officer of GELESIS HOLDINGS, INC.. Currently has a direct ownership of 314,090 shares of GLS, which is worth approximately $6,281. The most recent transaction as insider was on May 06, 2022, when has been sold 314,090 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 314K
0% 3M change
0% 12M change
Total Value Held $6,281

Harry L. Leider Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 06 2022
BUY
Grant, award, or other acquisition
-
314,090 Added 50.0%
314,090 Common Stock

Also insider at

OCEL
Organicell Regenerative Medicine, Inc. Healthcare
Chief Executive Officer
HLL

Harry L. Leider

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on GLS

Follow GELESIS HOLDINGS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLS shares.

Notify only if

Insider Trading

Get notified when an Gelesis Holdings, Inc. insider buys or sells GLS shares.

Notify only if

News

Receive news related to GELESIS HOLDINGS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GLS